Uniphos 200mg Injection

About

Uniphos 200mg Injection is an alkylating chemotherapy agent widely used in the treatment of various aggressive cancers. It functions as a prodrug, requiring metabolic activation in the liver to generate its active cytotoxic metabolites. These metabolites then interfere with the DNA of cancer cells by forming covalent cross-links, which effectively prevent DNA replication, transcription, and ultimately, cell division. This potent cytotoxic action is particularly effective against rapidly proliferating malignant cells. A critical consideration with Uniphos is its potential for urotoxicity, specifically severe hemorrhagic cystitis, caused by the metabolite acrolein. Therefore, it is almost invariably co-administered with mesna, a uroprotectant agent, to neutralize these toxic metabolites within the bladder and prevent bladder damage. It is a vital component in many established combination chemotherapy regimens.

Uses

• Treatment of germ cell testicular cancer.
• Management of soft tissue sarcomas.
• Therapy for lymphomas.
• Used in osteosarcoma.

Directions For Use

Administered intravenously by a healthcare professional, typically with mesna. Dosage and infusion schedule are determined by the doctor.

Benefits

• Effective against a range of solid tumors and lymphomas.
• Induces DNA damage and inhibits cancer cell proliferation.
• Can achieve significant tumor response.
• Often used in curative and palliative settings.
• Part of established combination chemotherapy regimens.
• Helps improve disease-free survival in certain cancers.

Side Effects

• Nausea and vomiting
• Myelosuppression (low blood counts)
• Hemorrhagic cystitis (bladder inflammation)
• Neurotoxicity (encephalopathy, confusion)
• Hair loss
• Fatigue
• Kidney dysfunction
• Liver enzyme elevations
• Anorexia
• Diarrhea
• Constipation
• Skin rash

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may exacerbate nausea, vomiting, and potentially liver toxicity.
• Pregnancy - Uniphos is highly teratogenic and contraindicated in pregnancy due to severe fetal harm. Effective contraception is essential.
• Breastfeeding - Breastfeeding is contraindicated during Uniphos therapy due to the risk of serious adverse effects in the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustments may be necessary, and liver function should be monitored.
• Kidney - Uniphos can cause nephrotoxicity. Close monitoring of renal function and adequate hydration are crucial.
• Lung - Rare but serious pulmonary toxicity can occur; monitor for respiratory symptoms, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.